The Silent Role of Biofilms in Chronic Disease › Forums › Biofilm Community › The Vets Corner › New InnovoSCEPTTM Veterinary Biofilm Tests
- This topic has 1 reply, 1 voice, and was last updated 13 years, 3 months ago by Harrison.
-
AuthorPosts
-
-
June 13, 2011 08:01 ET
Innovotech Receives First Purchase Order for New InnovoSCEPTTM Veterinary Biofilm Tests
EDMONTON, ALBERTA–(Marketwire – June 13, 2011) – Innovotech Inc. (TSX VENTURE:IOT), a pioneer in the field of biofilm product development, today announced that it has received its first purchase order for InnovoSCEPT veterinary biofilm susceptibility tests for launch into the Japanese veterinary market. The Company anticipates expansion to the balance of the worldwide veterinary market to follow quickly.
“This initial order of InnovoSCEPT veterinary tests provides a new and improved method to identify effective treatments for chronic infections in animals. The situation in the animal world parallels what is seen in human health, where inappropriate treatment of chronic infections results in unnecessary patient suffering, repeated treatment failures, increased health care costs and an increase in the potential for bacterial resistance,” said Ken Boutilier, President and CEO of Innovotech. “Our company has developed the InnovoSCEPT line of five new products for susceptibility testing in both humans and animals in less than six months. This initial purchase order for introduction into the Japanese market is just the start of what should become an important revenue generator.”
The InnovoSCEPT line of veterinary tests, based on the technology used to develop Innovotech’s bioFILM PA human susceptibility test, will assist veterinarians in the selection of the most effective antibiotic treatment of infections caused by both gram-positive and gram-negative bacteria in both small and large animals. As with human infections, many common disease-causing bacteria exist in animals as biofilms, such as those responsible for infections causing mastitis in dairy cows or persistent skin infections in family pets. These chronic infections are often difficult to eradicate and Innovotech’s tests have a much better chance of being successful in the identification of the best treatment approach in comparison to current methods.
Biofilms are organized communities of microorganisms that exist in virtually every natural environment. Biofilms can be up to 1000 times more resistant to treatment than the same organism in a free-floating state.
About Innovotech Inc.
Innovotech Inc. is a pioneer in the field of biofilm product development, focused on providing innovative and practical solutions to medical, agricultural and industrial problems caused by microbial biofilms. Biofilms are responsible for a host of diseases both in human health and agriculture due to their inherent resistance to existing antibiotics and disinfectants. Aside from Innovotech’s products there are no antibiotics, disinfectants, diagnostics or regulatory standards designed specifically for biofilm-forming organisms.
Innovotech has a broad range of products that address the issue of biofilms within a number of different industries, including three commercial products, the MBEC Assay, bioFILM PA and InnovoSCEPT veterinary kits. The MBEC Assay is a high throughput biofilm growth device that was recently approved as an ASTM International standard. bioFILM PA is the first diagnostic kit to assist physicians in the selection of the most effective combination antibiotic treatment of patients with biofilm-based chronic lung infections, while the InnovoSCEPT veterinary kits are designed to determine the most effective antibiotic treatment for infections in both large and small animals.
Innovotech also has two products in advanced stages of development; Agress® is a unique, environmentally friendly seed treatment and plant spray designed to protect crops against both bacterial and fungal infections and Sani-Lux is a light-activated, natural hard surface sanitizer.
Connect with us:
Website: Innovotech.ca Microbial, Bacterial and Biofilm Solutions
Blog: CF Test – A Breakthrough in Cystic Fibrosis Testing
Twitter:Innovotech (Innovotech) on Twitter
Facebook:Innovotech | Facebook
-
Innovotech Announces Distribution Agreement for InnovoSCEPT Veterinary Biofilm Tests
EDMONTON, ALBERTA–(Marketwire – July 12, 2011) – Innovotech Inc. (TSX VENTURE:IOT), a pioneer in the field of biofilm product development, today announced that Spectrum Labs Inc, specialists in veterinary allergy testing in the United States and over 40 countries worldwide, has been granted exclusive worldwide rights to market Innovotech’s InnovoSCEPT veterinary biofilm tests as part of its testing service. An initial order has already been placed, launching the veterinary testing service in the Japanese market earlier this month. The new service will be presented to Spectrum’s North American and global customers at the Central Veterinary Conference in Kansas City, August 24-30, 2011.
Many common infections in animals, such as mastitis in dairy cows and ear, dental or persistent skin infections in family pets, exist as organized colonies of bacteria, or biofilms. Biofilms can be up to 1000 times more resistant to treatment than the same organism in a free-floating state. The InnovoSCEPT line of biofilm susceptibility tests will help veterinarians choose the most effective antibiotic treatment for such infections in animals.
“We are excited to expand our current business through the InnovoSCEPT line of veterinary tests into animal biofilm susceptibility testing, for which there are currently no products,” said Mervyn Levin, CEO of Spectrum Labs. “Judging from the initial response, we expect to be performing several thousand of these assays every month. Not only will we be offering a further solution to dermatology, or allergy related problems associated with recurrent infections, but also solving an ongoing problem with warding off all chronic bacterial infections. We are looking forward to offering this to our existing clients in conjunction with our all new SPOT Platinum test but also to new markets outside of skin related conditions, in both the large and small animal arenas.”
“Innovotech is delighted to have joined forces with Spectrum Labs, whose expertise and leadership in the veterinary diagnostic arena will be invaluable in achieving the full commercial potential of the InnovoSCEPT veterinary biofilm tests,” said Ken Boutilier, President and CEO of Innovotech. “The decision to expand our product line to include veterinary biofilm tests, and our agreement with Spectrum, opens up a new market opportunity for Innovotech which we expect to translate into increased revenue in the near term.”
About Spectrum Labs Inc.
Allergy testing and treatment specialists, dedicated to veterinarians and their patients in 46 countries. Spectrum Labs has spent the last twenty plus years researching, developing, compiling, questioning and testing the traditional and emerging alike to uncover the best and most reliable tools and methodologies. Please visit Spectrum Labs | Vet Allergy Sollutions for more information on the company as well as its services and to get a preview of what is to come with both the becASSAY for biofilms and the all new SPOT Platinum test. The core focus of the company has always been and will remain quality results and superlative customer service.
About Innovotech Inc.
Innovotech Inc. is a pioneer in the field of biofilm product development, focused on providing innovative and practical solutions to medical, agricultural and industrial problems caused by microbial biofilms. Biofilms are organized communities of microorganisms that exist in virtually every natural environment and are responsible for a host of diseases in human health, animal health and agriculture. There are few products or regulatory standards, aside from those of Innovotech, designed specifically for biofilm-forming organisms.
Innovotech has a broad range of products that address the issue of biofilms within a number of different industries, including commercially available products in three market segments; the MBEC Assay(TM), bioFILM PA(TM) and InnovoSCEPT veterinary kits. The MBEC Assay(TM) is a high throughput biofilm growth device that was recently approved as an ASTM International standard. bioFILM PA(TM) is the first diagnostic kit to assist physicians in the selection of the most effective combination antibiotic treatment of patients with biofilm-based chronic lung infections, while the InnovoSCEPT veterinary kits are designed to determine the most effective antibiotic treatment for infections in both large and small animals.
Innovotech also has two products in advanced stages of development; Agress(R) is a unique, environmentally friendly seed treatment and plant spray designed to protect crops against both bacterial and fungal infections and Sani-Lux(TM) is a light-activated, natural hard surface sanitizer.
Connect with us:
Innovotech Inc.
Website: Innovotech.ca Microbial, Bacterial and Biofilm Solutions
Blog:CF Test A Breakthrough in Cystic Fibrosis Testing
Twitter:Innovotech (Innovotech) on Twitter
Facebook:Innovotech | FacebookSpectrum Labs Inc.
Twitter: Lyndee Kelver (vetallergy) on Twitter
Facebook: vetallergy – Health/Medical/Pharmaceuticals – Tempe, AZ | FacebookCONTACT INFORMATION:
Innovotech Inc.
Ken Boutilier
President and CEO
(780) 448-0585 ext. 221
Fax: (780) 424-0941
ken.boutilier (@) innovotech.caor
Innovotech Inc.
Amanda Stadel
Communications Officer
(780) 448-0585 ext. 224
Fax: (780) 424-0941
amanda.stadel (at) innovotech.ca
Innovotech.ca Microbial, Bacterial and Biofilm Solutionsor
Spectrum Labs Inc.
Mervyn Levin
CEO
(480) 464-8971
Fax: (480) 898-0611
mervyn(@)vetallergy.com
Spectrum Labs | Vet Allergy Sollutions
-
-
AuthorPosts
- You must be logged in to reply to this topic.